BAYESIAN NETWORK META-ANALYSIS (NMA) TO ASSESS THE RELATIVE EFFICACY OF CANAGLIFLOZIN MONOTHERAPY OVER 26 WEEKS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)

被引：1

作者：

Schroeder, M. ^{[1
]}

Taieb, V ^{[2
]}

Belhadi, D. ^{[2
]}

Seyla-Hammer, C. ^{[2
]}

Hemels, M. ^{[3
]}

Nielsen, A. T. ^{[3
]}

机构：

[1] Janssen Cilag UK, High Wycombe, Bucks, England

[2] Amaris London, London, England

[3] Janssen Cilag AS, Birker A D, Denmark

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jval.2015.03.329

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PDB22

引用

页码：A56 / A56

页数：1

共 50 条

[1] NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY OF EMPAGLIFLOZIN MONOTHERAPY OVER 24, 52, AND 76 WEEKS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Daacke, I
Batson, S.
Burton, H. E.
Tebboth, A.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A667 - A667
[2] BAYESIAN NETWORK META-ANALYSIS TO ASSESS RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED WITH METFORMIN
Pacou, M.
Taieb, V
Abrams, K. R.
Diels, J.
van Sanden, S.
Garg, M.
Schroeder, M.
Kaur, V
Nielsen, A. T. N.
Nuhoho, S.
Neslusan, C.
Hemels, M.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A609 - A609
[3] A BAYESIAN NETWORK META-ANALYSIS (NMA) FOR EVALUATING THE RELATIVE EFFICACY OF DUAL THERAPY COMBINATIONS OF DAPAGLIFLOZIN AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Bao, H.
Peng, X.
Li, W.
Xuan, J.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S43 - S43
[4] Efficacy and Safety of Canagliflozin (CANA) Monotherapy in Subjects With Type 2 Diabetes Mellitus (T2DM) Over 52 Weeks
Stenloef, Kaj
Cefalu, William T.
Kim, Kyoung-Ah
Jodar, Esteban
Alba, Maria
Edwards, Robert
Tong, Cindy
Canovatchel, William
Meininger, Gary
[J]. DIABETES, 2013, 62 : A303 - A303
[5] BAYESIAN NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN AND SULPHONYLUREA (MET plus SU)
Pacou, M.
Taieb, V
Abrams, K. R.
Diels, J.
van Sanden, S.
Garg, M.
Schroeder, M.
Kaur, V
Nielsen, A. T. N.
Nuhoho, S.
Neslusan, C.
Hemels, M.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A431 - A431
[6] Systematic Literature Review and Network Meta-analysis (NMA) of SGLT2i as Monotherapy for Type 2 Diabetes Mellitus (T2DM)
Davies, Glenn M.
Mcneill, Ann Marie
Kruger, Eliza
Kowal, Stacey L.
Ejzykowicz, Flavia
Hannachi, Hakima
Cater, Nilo B.
Mcleod, Euan
[J]. DIABETES, 2018, 67
[7] BAYESIAN NETWORK META-ANALYSIS (NMA) TO ASSESS RELATIVE EFFICACY OF CANAGLIFLOZIN (CANA) VERSUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS IN DUAL AND TRIPLE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Van Sanden, S.
Diels, J.
Guillon, P.
Nielsen, A. T.
[J]. VALUE IN HEALTH, 2015, 18 (03) : A54 - A54
[8] THE COMPARATIVE EFFICACY OF ORAL SEMAGLUTIDE FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (NMA)
Fazioli, K. T.
Borrelli, E.
Bradt, P.
Rind, D. M.
[J]. VALUE IN HEALTH, 2020, 23 : S109 - S109
[9] A NETWORK META-ANALYSIS (NMA) TO ASSESS THE LONGER-TERM RELATIVE EFFICACY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON METFORMIN
Taieb, V
Pacou, M.
Schroeder, M.
Nielsen, A. T.
Schubert, A.
Neslusan, C.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
[10] NETWORK META-ANALYSIS (NMA) TO ASSESS RELATIVE EFFICACY MEASURED AS PERCENTAGE OF PATIENTS TREATED TO HBA1C TARGET WITH CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN AND SULPHONYLUREA (MET plus SU)
Taieb, V
Pacou, M.
Schroeder, M.
Schubert, A.
Nielsen, A. T.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598

← 1 2 3 4 5 →